Similarly, TIMP1 has been proposed as a biomarker in colorectal cancer (AUC 0.95) and tropomyosin 3 (TPM3) in breast cancer (AUC 0.97) [194, 195]. This evidence concerns the gene TPM3 and breast carcinoma.